ClinicalTrials.Veeva

Menu

Identification and Verification of Neutrophil Extracellular Trap Net Related Markers in Acute-on-chronic Liver Failure

W

Wenzhou Medical University

Status

Not yet enrolling

Conditions

Acute-On-Chronic Liver Failure

Study type

Observational

Funder types

Other

Identifiers

NCT05909319
2023-3-14 version V1.0

Details and patient eligibility

About

Acute-on-chronic liver failure (ACLF) refers to the acute deterioration of liver function in patients with chronic liver disease. Neutrophils are a major component of the innate immune system, and previous studies have revealed enhanced production of neutrophil extracellular traps (NETs) in ACLF. However, there is still a lack of systematic research on the correlation between NETs and the prognosis of ACLF. We screened NETs related biomarkers through bioinformatics analysis, which play an important role in the diagnosis of ACLF. This study will explore whether these NETs related biomarkers also play an important role in the prognosis of ACLF and further investigate their role in the pathogenesis of ACLF.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patients who meet the diagnostic criteria of Chinese Group on the Study of Severe Hepatitis B (COSSH) for acute-on-chronic liver failure

Exclusion criteria

  1. Age greater than 75 years old
  2. liver cancer
  3. previous liver transplantation
  4. other serious extrahepatic organ diseases
  5. uncontrolled bacterial infections.

Trial design

200 participants in 1 patient group

ACLF

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems